Fanconi Anemia
📧 Sign up to get email alerts when something new happens for Fanconi Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Safety and Efficacy Trial of Danazol in Patients With Fanconi Anemia or Dyskeratosis Congenita [Phase 1, Phase 2]
The Phase 1/2 safety and efficacy trial of danazol in patients with Fanconi anemia or Dyskeratosis Congenita was terminated, and results hav…
-
CLINICAL_TRIALS trial_result · 2018-07-10Clinical Trial Update: Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine [Phase 2]
Phase 2 trial evaluating hematopoietic stem cell transplantation after a chemotherapy-only cytoreduction with busulfan, cyclophosphamide, an…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Gene Function in Bone Marrow Cells From Patients With Fanconi Anemia and From Healthy Participants
A terminated clinical trial update examining gene function in bone marrow cells from patients with Fanconi anemia and from healthy participa…
-
CLINICAL_TRIALS trial_result · 2017-12-04Clinical Trial Update: Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers
A completed clinical trial evaluating cell damage from alkylating agents in patients with acute myeloid leukemia, myelodysplastic syndromes,…
-
CLINICAL_TRIALS trial_result · 2017-11-29Clinical Trial Update: Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [NA]
ClinicalTrials.gov entry describes termination of a study evaluating donor umbilical cord blood transplantation for various hematologic canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias [Phase 2]
Phase 2 study of deferasirox for iron overload in beta-thalassemia patients who cannot be treated with deferoxamine, as well as related chro…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Gene Therapy for the Treatment of Fanconi's Anemia Type C [Phase 1]
A Phase 1 gene therapy trial for Fanconi anemia (Type C) has completed. The study addressed pancytopenia associated with the condition.
-
CLINICAL_TRIALS trial_result · 2017-06-23Clinical Trial Update: Bone Marrow Cell Gene Transfer in Individuals With Fanconi Anemia [Phase 1]
Phase 1 trial evaluating bone marrow cell gene transfer in individuals with Fanconi Anemia. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia [Phase 2]
Phase 2 trial evaluating a conditioning regimen with fludarabine, cyclophosphamide, and total-body irradiation followed by donor bone marrow…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia [Phase 1]
Phase 1 trial evaluating low-dose total-body irradiation and fludarabine phosphate followed by an unrelated donor stem cell transplant in pa…
-
CLINICAL_TRIALS trial_result · 2016-08-10Clinical Trial Update: Hematopoietic Stem Cell Transplantation for Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using Total Body Irradiation, Cyclophosphamide and Fludarabine [NA]
This completed clinical trial evaluated hematopoietic stem cell transplantation with a conditioning regimen of total body irradiation, cyclo…
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
A clinical trial update reports identification of de novo Fanconi anemia in younger patients with newly diagnosed acute myeloid leukemia, im…
-
CLINICAL_TRIALS trial_result · 2016-04-14Clinical Trial Update: Cord Blood Stem Cell Transplantation Study (COBLT) [Phase 2]
Phase 2 COBLT cord blood stem cell transplantation trial sponsored by NHLBI has completed, studying transplantation for aplastic anemia, Fan…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
A completed clinical trial from University Hospital Freiburg evaluating immune function in young cytopenia patients unresponsive to treatmen…
-
CLINICAL_TRIALS trial_result · 2014-03-04Clinical Trial Update: Use of Rft5-Dga to Deplete Alloreactive Cells for Pts With Fanconi Anemia After Haploidentical SCT [Phase 1]
A Phase 1 trial evaluating Rft5-Dga to deplete alloreactive cells in Fanconi anemia patients after haploidentical stem cell transplantation …
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases [Phase 2]
Phase 2 clinical trial evaluating umbilical cord blood stem cell transplantation for treating malignant and nonmalignant diseases in young p…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission [Phase 1, Phase 2]
This completed Phase 1/2 trial from UCSF evaluated a conditioning regimen of busulfan, antithymocyte globulin, and fludarabine followed by d…
-
CLINICAL_TRIALS trial_result · 2012-08-09Clinical Trial Update: Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia [Phase 1, Phase 2]
A phase 1/2 trial evaluating an antibody conditioning regimen for allogeneic donor stem cell transplantation in patients with Fanconi anemia…
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Cyclophosphamide in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Fanconi's Anemia [Phase 1]
Phase 1 study evaluating cyclophosphamide in patients undergoing donor bone marrow transplant for Fanconi anemia has completed. The trial sp…
-
CLINICAL_TRIALS trial_result · 2011-07-15Clinical Trial Update: Oxandrolone for the Treatment of Bone Marrow Aplasia in Fanconi Anemia [Phase 1]
Phase 1 trial evaluating oxandrolone for bone marrow aplasia in Fanconi anemia has completed.
-
CLINICAL_TRIALS trial_result · 2009-11-26Clinical Trial Update: Stem Cell Transplantation for Fanconi Anemia [Phase 1, Phase 2]
Phase 1/2 trial of stem cell transplantation for Fanconi anemia was terminated; results posted in 2009.